Navigation Links
New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder

Nausea generally was transient, usually resolving within the first week. Nine patients (9 percent) had hypertension during the trial. Six patients reported a serious adverse event, none of which was considered related to desvenlafaxine succinate. Adverse events were noted as the cause of discontinuation from the study in about one-third of patients -- with the majority of discontinuations occurring in the first week. Study findings also showed that HAM-D17 mean total scores steadily decreased from baseline at Day 7 through Day 60 and continued to decrease through the end of the study.

Poster NR363: Ahmed S, et al. Switch from Venlafaxine to Desvenlafaxine Succinate Is Well-Tolerated in Patients with Major Depressive Disorder

In this study, patients taking venlafaxine ER were able to transition to desvenlafaxine succinate with a lower incidence of nausea than patients who switched from placebo to 200 mg/day of desvenlafaxine succinate. Furthermore, patients who switched from venlafaxine ER to desvenlafaxine succinate and those who remained on desvenlafaxine succinate were less likely to discontinue therapy than patients who switched from placebo to 200 mg/day of desvenlafaxine succinate (without titration).

Before joining the 10-week, open-label study, 517 patients completed one of two eight-week, double-blind, placebo-controlled, flexible-dose studies of desvenlafaxine succinate and venlafaxine ER. Patients who received either placebo (n=186) or venlafaxine ER (n=183) during the double-blind study began the open-label phase at 200 mg/day of desvenlafaxine succinate, while patients who took desvenlafaxine succinate (n=148) during the double-blind study remained on the same dose at the beginning of the open-label study. Based on clinical response, each patient's dose of desvenlafaxine succinate could be adjusted during the open-label study.

Study findings show that overall treatment-emergent adverse events reported during the 10-week study
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) today announced ... highlights: , Sales in local currency increased ... Reported sales decreased 4% as currency reduced sales growth ... per diluted share as reported (EPS) were $2.73, compared ... $2.80 , an increase of 9% over the ...
(Date:7/30/2015)... July 30, 2015  Tandem Diabetes Care®, Inc. ... and manufacturer of the t:slim® and t:flex™ Insulin ... non-exclusive Development Agreements with Dexcom, Inc. to allow ... with the Dexcom G5 and G6 continuous glucose ... generation pump platform with Dexcom,s future CGM systems ...
(Date:7/30/2015)... BOTHELL, Wash. and VANCOUVER ... OGXI ) announced today that it will report ... 13, 2015. Company management will host a conference call ... provide an overview of financial results, clinical development programs ... access the webcast, log on to the Investor Relations ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... Amex: NBS ) ("NeoStem" or the "Company"), an ... development, today reported third quarter results and recent progress in ... for the three and nine months ended September 30, 2011. ... 2011 were $17.8 million and $55.9 million compared to $16.5 ...
... WARSAW, Ind., Nov. 10, 2011 Zimmer Holdings, Inc. ... that it has acquired Memphis-based ExtraOrtho, Inc., including its ... "This acquisition further enhances Zimmer,s position in the vital ... Zimmer Global Businesses.  "The XtraFix technology is one of ...
Cached Medicine Technology:NeoStem Provides Updates, Reports Results for Third Quarter and Upcoming November Company Presentations 2NeoStem Provides Updates, Reports Results for Third Quarter and Upcoming November Company Presentations 3NeoStem Provides Updates, Reports Results for Third Quarter and Upcoming November Company Presentations 4NeoStem Provides Updates, Reports Results for Third Quarter and Upcoming November Company Presentations 5Zimmer Announces Acquisition of XtraFix® External Fixation System 2Zimmer Announces Acquisition of XtraFix® External Fixation System 3
(Date:8/1/2015)... ... August 01, 2015 , ... Tina Wilcoxson, owner of Freeport Maine’s ... given that honor by the National Retail Federation, the largest retail trade association in ... of three Maine business owners to be named as such. According to the NRF’s ...
(Date:8/1/2015)... Dallas, TX (PRWEB) , ... August 01, 2015 , ... ... support for the March4thforWellBeing foundation, making hers the very first small business donation to ... and look beautiful for over thirty years. Her legacy includes a complete line of ...
(Date:7/31/2015)... ... July 31, 2015 , ... When the weather turned hot ... their new type of sod called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) ... To commemorate introduction of this new type of sod, Super-Sod is giving away red ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
(Date:7/31/2015)... FL (PRWEB) , ... July 31, 2015 , ... ... announced an important workshop at its new True North Conference Center. The medical ... so that the Jacksonville community may be more aligned in the effort to ...
Breaking Medicine News(10 mins):Health News:Local Retail Advocate Wins National Recognition 2Health News:March4thforWellBeing Foundation Kickoff 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3
... Pharmacy To Inspire Others to Manage Chronic Conditions , ... tour, "Iron Andy" Holder, an Ironman competitor who was diagnosed with ... at a Don Quijote Pharmacy in Honolulu today. , ... 1 diabetes, who was inspired by Andy,s personal story. The two ...
... Medical International Technology Inc. (MDLH.PK) ( http://www.mitcanada.ca ... Mr. Michel Bayouk, our former Corporate Secretary, Principal Accounting ... Michel Bayouk tendered his resignation from Medical International Technology ... officer due to health related reasons. , June 1st ...
... to Service Award , , ST. GEORGE,S, Bermuda, ... Kerwin of Oxford Communications ( www.oxfordcommunications.bm ), Bermuda,s premier ... will be the primary sponsor of The Bermuda Health ... 17th and Celebrity Golf Tournament to be held June ...
... time learning to speak, researchers say , THURSDAY, June ... parents and infants, which could delay children,s language development, ... infant-targeted DVDs actually benefit youngsters. , The researchers studied ... found that for each additional hour of television exposure, ...
... Storylines, Counter Misconceptions About Organ Donation , , ,ER, ... , , LOS ANGELES, June 2 The inaugural ... Directors Guild in Los Angeles, featuring inspiring stories of lives ... and entertaining panels of screenwriters and surgeons. , ...
... Advantage Network employees did a little leg work one ... for Research on Schizophrenia and Depression . In fact, they ... http://www.newscom.com/cgi-bin/prnh/20090602/DC26325 ) , , Nine employees raised more than ... walk at Kinder Farm Park in Millersville, Md. , ...
Cached Medicine News:Health News:Ironman Competitor with Diabetes Inspires Individuals with Diabetes to Live Without Limits 2Health News:Mr. Michel Bayouk resignation and passing 2Health News:Jim Kerwin Announces Oxford Communications To Be the Title Sponsor of Bermuda Health Foundation Salute for the Second Year 2Health News:TV Interferes With Infants' Language Development 2Health News:Donate Life Hollywood Inaugurates Film Festival - June 13 2Health News:Donate Life Hollywood Inaugurates Film Festival - June 13 3Health News:Donate Life Hollywood Inaugurates Film Festival - June 13 4Health News:Donate Life Hollywood Inaugurates Film Festival - June 13 5Health News:A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 2
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Severe revision options for the knee and hip...
Medicine Products: